Using mass spectrometry-based proteomics to improve the understanding of multiple sclerosis treatments

RR Lereim - 2021 - bora.uib.no
In this work, the effects of multiple sclerosis (MScl) treatments were investigated by
quantitative proteomics. First, the effects of the anti-inflammatory drug Fingolimod was …